Bio-Rad Laboratories (BIO) Free Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 16.06% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 69.50% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -21.08% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 56.67% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -6.83% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -5.79% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 27.54% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -4.61% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 28.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.79% |
| Mar 31, 2026 | -18.22% |
| Dec 31, 2025 | 46.49% |
| Sep 30, 2025 | -27.71% |
| Jun 30, 2025 | 28.03% |
| Mar 31, 2025 | 222.64% |
| Dec 31, 2024 | 109.89% |
| Sep 30, 2024 | 130.10% |
| Jun 30, 2024 | -12.83% |
| Mar 31, 2024 | -52.56% |
| Dec 31, 2023 | -13.51% |
| Sep 30, 2023 | 423.55% |
| Jun 30, 2023 | 76.39% |
| Mar 31, 2023 | 258.13% |
| Dec 31, 2022 | -60.96% |
| Sep 30, 2022 | -108.47% |
| Jun 30, 2022 | -72.59% |
| Mar 31, 2022 | -81.48% |
| Dec 31, 2021 | -53.28% |
| Sep 30, 2021 | 69.19% |